Skip to main content
Clinical Trials/NCT03966560
NCT03966560
Completed
Phase 4

Choroidal Thickness and Its Correlations With Ocular Parameters in Cases With Primary Open-angle Glaucoma

Afyon Kocatepe University Hospital0 sites96 target enrollmentJanuary 2014

Overview

Phase
Phase 4
Intervention
Brimonidine Tartrate
Conditions
Glaucoma, Open-Angle
Sponsor
Afyon Kocatepe University Hospital
Enrollment
96
Primary Endpoint
Changes in impulse times of P1 wave in Ring-1, Ring-2, Ring-3 and Ring-4 [ms]
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Glaucoma is one of the leading causes of blindness worldwide that is a chronic public health problem. Unfortunately, glaucoma can be diagnosed when the disease reaches a certain level in today's conditions. The aim of this study was to investigate the diagnostic methods that can diagnose glaucoma before it reaches the advanced level and to identify pathophysiological processes. In this study, choroidal thickness was investigated in primary open-angle glaucoma cases and its correlations with OCT and multifocal ERG parameters were evaluated.

Detailed Description

In this study, patients with primary open-angle glaucoma who have recently received a new diagnosis with healthy volunteers with age-matched groups were enrolled. All data from 49 glaucoma patients and 47 healthy volunteers were recorded and the study was completed. The study was carried out at the Afyon Kocatepe University Ophthalmology Department between January 2014 and April 2015. Routine ophthalmologic examinations of all participants were performed. Medical treatment was initiated on patients diagnosed with primary open-angle glaucoma. Intraocular pressures and visual acuities of all participants were recorded at baseline, at 1-month, at 3-month, and at 6-month. All participants underwent tests of multifocal electroretinography and the measurements of optic nerve head optical coherence tomography parameters and the choroidal thickness, at the same follow-ups. Visual acuities were measured by using the Snellen chart as the best corrected visual acuity. Intraocular pressures were measured by using applanation tonometry. Choroid thicknesses were also measured and recorded using EDI-OCT mode of optical coherence tomography device (Cirrus HD 4000, Carl Zeiss Meditec AG, Germany). Choroidal thicknesses were measured in three regions: fovea, 3mm nasal and temporal distances of the fovea. The mean of these three measurements was recorded as macular choroidal thickness. The same technician performed all multifocal electroretinography tests of the participants (Metrovision Monpack 3, Metrovision, France). Multifocal electroretinography tests were carried out from a distance of 33 cm using ERG-jet electrode, ground electrode, and a reference electrode. Electrical potential responses from 103 retina regions were recorded. Results were compared statistically and correlations were analyzed (SPSS 20.0, SPSS Inc. IL, USA).

Registry
clinicaltrials.gov
Start Date
January 2014
End Date
April 2015
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Afyon Kocatepe University Hospital
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Arms & Interventions

Primary open-angle glaucoma

Participants over 40 years of age and diagnosed with primary open-angle glaucoma. Medical treatment was initiated for the diagnosed participants.

Intervention: Brimonidine Tartrate

Primary open-angle glaucoma

Participants over 40 years of age and diagnosed with primary open-angle glaucoma. Medical treatment was initiated for the diagnosed participants.

Intervention: Dorzolamide (as Dorzolamide Hydrochloride) 20 Mg/mL and Timolol (as Timolol Maleate) 5 Mg/mL Eye Drops

Primary open-angle glaucoma

Participants over 40 years of age and diagnosed with primary open-angle glaucoma. Medical treatment was initiated for the diagnosed participants.

Intervention: Brinzolamide/Timolol 10 MG/1 ML-5 MG/1 ML Ophthalmic Suspension

Primary open-angle glaucoma

Participants over 40 years of age and diagnosed with primary open-angle glaucoma. Medical treatment was initiated for the diagnosed participants.

Intervention: Travoprost and Timolol

Primary open-angle glaucoma

Participants over 40 years of age and diagnosed with primary open-angle glaucoma. Medical treatment was initiated for the diagnosed participants.

Intervention: Bimatoprost and Timolol

Primary open-angle glaucoma

Participants over 40 years of age and diagnosed with primary open-angle glaucoma. Medical treatment was initiated for the diagnosed participants.

Intervention: Latanoprost

Outcomes

Primary Outcomes

Changes in impulse times of P1 wave in Ring-1, Ring-2, Ring-3 and Ring-4 [ms]

Time Frame: Baseline, 1-month, 3-month, 6-month

Comparison of the mean impulse times of P1 wave \[ms\] in Ring-1, Ring-2, Ring-3 and Ring-4) at baseline, at 1-month, at 3-month and at 6-month

Changes in multifocal electroretinography parameters (Amplitudes [nv/deg2] and impulse times [ms] of N1, N2 and P1 waves in Ring-1, Ring-2, Ring-3 and Ring-4)

Time Frame: Baseline, 1-month, 3-month, 6-month

Comparison of the mean multifocal electroretinography parameters (Amplitudes \[nv/deg2\] and impulse times \[ms\] of N1, N2 and P1 waves in Ring-1, Ring-2, Ring-3 and Ring-4) at baseline, at 1-month, at 3-month and at 6-month

Changes in amplitudes of N1 wave in Ring-1, Ring-2, Ring-3 and Ring-4 [nv/deg2]

Time Frame: Baseline, 1-month, 3-month, 6-month

Comparison of the mean amplitudes of N1 wave \[nv/deg2\] in Ring-1, Ring-2, Ring-3 and Ring-4) at baseline, at 1-month, at 3-month and at 6-month

Changes in the mean cup-to-disc ratios

Time Frame: Baseline, 1-month, 3-month, 6-month

Measuring cup-to-disc ratios at 1-month, at 3-month and at 6-month

Changes in the mean disc area [mm2]

Time Frame: Baseline, 1-month, 3-month, 6-month

Measuring disc area \[mm2\] at 1-month, at 3-month and at 6-month

Macular choroidal thickness measure

Time Frame: Baseline, 1-month, 3-month, 6-month

Measuring macular choroidal thickness at baseline, at 1-month, at 3-month and at 6-month by using optical coherence tomography

Changes in impulse times of N1 wave in Ring-1, Ring-2, Ring-3 and Ring-4 [ms]

Time Frame: Baseline, 1-month, 3-month, 6-month

Comparison of the mean impulse times of N1 wave \[ms\] in Ring-1, Ring-2, Ring-3 and Ring-4) at baseline, at 1-month, at 3-month and at 6-month

Changes in P1/N1 ratio of N2 wave in Ring-1, Ring-2, Ring-3 and Ring-4

Time Frame: Baseline, 1-month, 3-month, 6-month

Comparison of the mean P1/N1 ratios of N2 wave in Ring-1, Ring-2, Ring-3 and Ring-4) at baseline, at 1-month, at 3-month and at 6-month

Changes in the mean retinal nerve fiber layer thickness [micrometers]

Time Frame: Baseline, 1-month, 3-month, 6-month

Measuring retinal nerve fiber layer thicknesses \[micrometers\] at 1-month, at 3-month and at 6-month

Changes in amplitudes of N2 wave in Ring-1, Ring-2, Ring-3 and Ring-4 [nv/deg2]

Time Frame: Baseline, 1-month, 3-month, 6-month

Comparison of the mean amplitudes of N2 wave \[nv/deg2\] in Ring-1, Ring-2, Ring-3 and Ring-4) at baseline, at 1-month, at 3-month and at 6-month

Changes in amplitudes of P1 wave in Ring-1, Ring-2, Ring-3 and Ring-4 [nv/deg2]

Time Frame: Baseline, 1-month, 3-month, 6-month

Comparison of the mean amplitudes of P1 wave \[nv/deg2\] in Ring-1, Ring-2, Ring-3 and Ring-4) at baseline, at 1-month, at 3-month and at 6-month

Changes in the mean optic nerve head optical coherence tomography parameters (Retinal nerve fiber layer thickness [micrometers], disc area [mm2], cup-to-disc ratios, cup volume [mm3], neuroretinal rim area [mm2])

Time Frame: Baseline, 1-month, 3-month, 6-month

Measuring optic nerve head optical coherence tomography parameters (Retinal nerve fiber layer thickness \[micrometers\], disc area \[mm2\], cup-to-disc ratios, cup volume \[mm3\], neuroretinal rim area \[mm2\]) at 1-month, at 3-month and at 6-month

Changes in the mean neuroretinal rim area [mm2])

Time Frame: Baseline, 1-month, 3-month, 6-month

Measuring neuroretinal rim area \[mm2\] at 1-month, at 3-month and at 6-month

Changes in the mean cup volume [mm3]

Time Frame: Baseline, 1-month, 3-month, 6-month

Measuring cup volume \[mm3\] at 1-month, at 3-month and at 6-month

Secondary Outcomes

  • Best-corrected visual acuity measure(Baseline, 1-month, 3-month, 6-month)
  • Intraocular pressure measure(Baseline, 1-month, 3-month, 6-month)
  • Correlations between choroidal thickness and other parameters(Baseline, 6-month)

Similar Trials